Regulatory approval and a first‐in‐human phase I clinical trial of a monoclonal antibody produced in transgenic tobacco plants

Overview of attention for article published in Plant Biotechnology Journal, July 2015

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#38 of 2,413)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 13 news outlets
policy: 1 policy source
twitter: 6 X users

facebook: 1 Facebook page
f1000: 1 research highlight platform

Readers on

mendeley: 275 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 13 news stories from 13 outlets.

Cómo la controvertida planta podría usarse para bien

Espanol.news, 15 Mar 2025

El tabaco mata 8 millones de personas En todo el mundo todos los años, pero imagine si podría usarse para hacer medicamentos.

Explained | Tobacco’s hidden friendly side: How controversial plant could be used for good

The Deccan Herald, 15 Mar 2025

Tobacco became a panacea in 16th century Europe, prescribed for almost everything.

How genetic engineering turning tobacco as critical asset in future of healthcare

The Telegraph (india), 15 Mar 2025

Tobacco kills 8 million people worldwide every year, but imagine if it could be used to make medicine.

Tobacco’s hidden friendly side: how controversial plant could be used for good

News Drum, 15 Mar 2025

London, Mar 15 (The Conversation) Tobacco kills 8 million people worldwide every year, but imagine if it could be used to make…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 9 additional news stories.